Investors & News
Careers
Contact Us
Share
About Omeros
About Omeros
Leadership
Science
Research Areas
Discovery
Technologies
Scientific
Publications
Pipeline
Pipeline Overview
Narsoplimab
(OMS721)
OMS405
OMS527
OMS906
OMS1029
MASP-2, MASP-3,
MASP-2/-3
GPR174
Adoptive T Cell Therapies /CAR T
GPCR Platform
Medical Information Request
Patients
Commitment
to Patients
Search
Investors & News
Careers
Contact Us
Share
Characterization of narsoplimab, a selective inhibitor of lectin pathway-mediated complement activation and thrombosis
Home
Publications
Characterization of narsoplimab, a selective inhibitor of lectin pathway-mediated complement activation and thrombosis
Prev
Next
Privacy Preference Center
Privacy Preferences